Drug Type Peptides |
Synonyms DWPDARGIWHND |
Target |
Action agonists, stimulants |
Mechanism KEAP1 agonists(Kelch-like ECH-associated protein 1 agonists), Nrf2 stimulants(Nuclear factor erythroid 2-related factor 2 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| stress oxidative | Preclinical | China | 01 Apr 2026 |





